Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Expedition resupplies for ph. 2 COPD voyage with $165M series A
The new funding will fuel the Bay Area biotech’s Fosun-licensed DPP1 inhibitor in COPD and other neutrophil-driven inflammatory diseases.
Darren Incorvaia
Oct 9, 2025 9:50am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
